Latest AstraZeneca Stories
SAN FRANCISCO, April 23, 2015 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the first quarter ended March 31, 2015 on Thursday, April 30, 2015, after
BASEL, Switzerland, April 23, 2015 /PRNewswire/ -- -- Searchable, useable and shareable data on The Good Growth Plan -- Open Data Institute collaboration a first for the agriculture
GAITHERSBURG, Md., April 22, 2015 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the Board of Directors of GenVec, Inc.
Results presented at American Association of Cancer Research Annual Meeting 2015, Philadelphia, April 18-22 PHILADELPHIA, April 22, 2015 /PRNewswire/ -- Researchers at the Cancer Research
DALLAS, April 21, 2015 /PRNewswire/ -- LifeScienceIndustryResearch.com adds Human Papillomavirus Infections - Pipeline Review, H1 2015 and offers Human Papillomavirus Infections
DUBLIN, April 20, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zbfftz/cns_therapeutics) has announced the addition of the "CNS
FREMONT, Calif., April 20, 2015 /PRNewswire/ -- Ardelyx, Inc.
GENEVA, April 17, 2015 /PRNewswire/ -- ASSESS shows plasma circulating tumour DNA (ctDNA) testing for EGFR mutation is a viable alternative
BASEL, Switzerland, April 17, 2015 /PRNewswire/ -- -- Integrated sales up one percent at constant exchange rates -- Reported sales impacted by currency; full year earnings
OXFORD, England, April 16, 2015 /PRNewswire/ -- Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer and other diseases,
- A person in a secondary role, specifically the second most important character (after the protagonist).